Next Generation Monitoring: M-inSight® Clinical Application In Multiple Myeloma
M-inSight® was employed monitor routine patient from the clinic. This study examines the correlation between M-protein quantification using M-inSight® and conventional serum protein electrophoresis (SPEP) values routinely obtained in clinical settings. The results show the ability to seamlessly integrate M-inSight® into routine monitoring protocols offers clinicians a valuable tool for MRD monitoring, tracking disease progression and response to therapy with enhanced sensitivity and specificity.